Innate immunity plays a key role in the host's early surveillance against an infectious challenge. The immediate barriers to noxious stimuli take on many guises. The molecules that are involved in innate immunity in higher organisms, like mice and men, often have their origins in very primitive life-forms that lack specific immunity. In this proposal, we aim to extend our investigations into one such molecule in which we have had a long-standing interest. The mannose-binding protein (a.k.a. the mannan-binding protein and mannose-binding lectin) may be considered as an ante-antibody . The role for the mannose-binding protein as an antecedent of antibodies is based on convincing in vitro evidence against an infectious agent during the lag period prior to the generation of a specific immune response. The goals of this proposal are to determine the precise in vivo role for the mannose-binding protein in host defense. We have generated MBP-A null mice that will allow a determination of whether an absolute or relative lack of the mannose-binding protein predisposes to infection. We plan to generate double knockout mice which will allow us to determine the relative roles of the mannose-binding protein, complement and natural antibodies in first line host defense. We also plan to define the structural basis by which the mannose-binding protein multimers bind ligands. It is anticipated that these structural studies will provide important new information as to how the mannose-binding protein is able to recognize the patterns of carbohydrates that adorn the surfaces of a wide range of bacterial, fungal and viral agents, yet interact with a paucity of self glycoproteins. The studies described in this proposal, if successful, will complement and add significant credence to the clinical observations that lack of the mannose-binding protein particularly in children below the age of two predisposes them to recurrent infections. The availability of recombinant mannose-binding protein will provide immediate opportunities for replacement therapy in selected individuals in a manner analogous to the use of gammaglobulin replacement in hypogammaglobulinemia.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI042788-04
Application #
6631998
Study Section
Allergy and Immunology Study Section (ALY)
Program Officer
Winter, David B
Project Start
2000-03-01
Project End
2005-02-28
Budget Start
2003-03-01
Budget End
2004-02-29
Support Year
4
Fiscal Year
2003
Total Cost
$379,563
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
02199
Moller-Kristensen, Mette; Ip, W K Eddie; Shi, Lei et al. (2006) Deficiency of mannose-binding lectin greatly increases susceptibility to postburn infection with Pseudomonas aeruginosa. J Immunol 176:1769-75
Takahashi, Kazue; Shi, Lei; Gowda, Lakshmi D et al. (2005) Relative roles of complement factor 3 and mannose-binding lectin in host defense against infection. Infect Immun 73:8188-93
Stuart, Lynda M; Takahashi, Kazue; Shi, Lei et al. (2005) Mannose-binding lectin-deficient mice display defective apoptotic cell clearance but no autoimmune phenotype. J Immunol 174:3220-6
Stuart, Lynda M; Ezekowitz, R Alan B (2005) Phagocytosis: elegant complexity. Immunity 22:539-50
Shi, Lei; Takahashi, Kazue; Dundee, Joseph et al. (2004) Mannose-binding lectin-deficient mice are susceptible to infection with Staphylococcus aureus. J Exp Med 199:1379-90
Fraser, Iain P; Stuart, Lynda; Ezekowitz, R Alan B (2004) TLR-independent pattern recognition receptors and anti-inflammatory mechanisms. J Endotoxin Res 10:120-4
Ezekowitz, R Alan (2003) Role of the mannose-binding lectin in innate immunity. J Infect Dis 187 Suppl 2:S335-9
Takahashi, Kazue; Gordon, Judith; Liu, Hong et al. (2002) Lack of mannose-binding lectin-A enhances survival in a mouse model of acute septic peritonitis. Microbes Infect 4:773-84